tiprankstipranks
NanoVibronix Inc (NAOV)
NASDAQ:NAOV

NanoVibronix (NAOV) Stock Price & Analysis

231 Followers

NAOV Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.70 - $4.34
Previous Close$0.75
Volume3.48K
Average Volume (3M)100.47K
Market Cap
$2.09M
Enterprise Value-$1.68M
Total Cash (Recent Filing)$3.79M
Total Debt (Recent Filing)$19.00K
Price to Earnings (P/E)-0.4
Beta1.49
May 17, 2022
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.13
Shares Outstanding2,784,354
10 Day Avg. Volume22,400
30 Day Avg. Volume100,473
Standard Deviation0.33
R-Squared0.04
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.46
Price to Sales (P/S)-20.47
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.67
Enterprise Value/Gross Profit-10.06
Enterprise Value/Ebitda0.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

4.70%2.12%1.53%91.65%
4.70%
Insiders
1.53% Other Institutional Investors
91.65% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

NAOV FAQ

What was NanoVibronix Inc’s price range in the past 12 months?
NanoVibronix Inc lowest stock price was $0.70 and its highest was $4.34 in the past 12 months.
    What is NanoVibronix Inc’s market cap?
    Currently, no data Available
    When is NanoVibronix Inc’s upcoming earnings report date?
    NanoVibronix Inc’s upcoming earnings report date is May 17, 2022 which is 703 days ago.
      How were NanoVibronix Inc’s earnings last quarter?
      NanoVibronix Inc released its earnings results on Nov 16, 2021. The company reported -$5.116 earnings per share for the quarter, missing the consensus estimate of N/A by -$5.116.
        Is NanoVibronix Inc overvalued?
        According to Wall Street analysts NanoVibronix Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does NanoVibronix Inc pay dividends?
          NanoVibronix Inc does not currently pay dividends.
          What is NanoVibronix Inc’s EPS estimate?
          NanoVibronix Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does NanoVibronix Inc have?
          NanoVibronix Inc has 2,784,354 shares outstanding.
            What happened to NanoVibronix Inc’s price movement after its last earnings report?
            NanoVibronix Inc reported an EPS of -$5.116 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.098%.
              Which hedge fund is a major shareholder of NanoVibronix Inc?
              Currently, no hedge funds are holding shares in NAOV
              ---

              NanoVibronix Stock Smart Score

              Company Description

              NanoVibronix Inc

              NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. It targets wound healing and pain therapy, and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Melville, NY.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              NovaBay Pharma
              Nemaura Medical
              Lineage Therap
              BioNano Genomics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis